|
Sample Name |
---|
|
Ellis_126_3303_3121_10 |
Ellis_126_3303_3122_10 |
Ellis_126_3303_3121_01 |
Ellis_126_3303_3121_02 |
Ellis_126_3303_3121_03 |
Ellis_126_3303_3121_04 |
Ellis_126_3303_3121_05 |
Ellis_126_3303_3121_06 |
Ellis_126_3303_3122_01 |
Ellis_126_3303_3122_02 |
Ellis_126_3303_3123_10 |
Ellis_126_3303_3124_10 |
Ellis_126_3303_3125_10 |
Ellis_126_3303_3126_10 |
Ellis_126_3303_3122_03 |
Ellis_126_3303_3122_04 |
Ellis_126_3303_3122_05 |
Ellis_126_3303_3122_06 |
Ellis_126_3303_3127_10 |
Ellis_126_3303_3123_01 |
Ellis_126_3303_3123_02 |
Ellis_126_3303_3128_10 |
Ellis_126_3303_3129_10 |
Ellis_126_3303_3123_03 |
Ellis_126_3303_3123_04 |
Ellis_126_3303_3123_05 |
Ellis_126_3303_3123_06 |
Ellis_126_3303_31210_10 |
Ellis_126_3303_31211_10 |
Ellis_126_3303_31212_10 |
---|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
---|
Carbamidomethyl Cysteine | ACANDLLVDEFLK | | >sp|Q99683|M3K5_HUMAN Mitogen-activated protein kinase kinase kinase 5 OS=Homo sapiens GN=MAP3K5 PE=1 SV=1 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Phospho (ST) | ANSFVGTAQYVSPELLTEK | | >sp|O15530|PDPK1_HUMAN 3-phosphoinositide-dependent protein kinase 1 OS=Homo sapiens GN=PDPK1 PE=1 SV=1 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Carbamidomethyl Cysteine | AVEVACYVCK | | >sp|P45985|MP2K4_HUMAN Dual specificity mitogen-activated protein kinase kinase 4 OS=Homo sapiens GN=MAP2K4 PE=1 SV=1 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Carbamidomethyl Cysteine | AVEVACYVCK | | >sp|P45985|MP2K4_HUMAN Dual specificity mitogen-activated protein kinase kinase 4 OS=Homo sapiens GN=MAP2K4 PE=1 SV=1 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Carbamidomethyl Cysteine | CLHDIALAHR | | >sp|Q96B36|AKTS1_HUMAN Proline-rich AKT1 substrate 1 OS=Homo sapiens GN=AKT1S1 PE=1 SV=1 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Carbamidomethyl Cysteine | CLSYGGTSQLR | | >sp|O95382|M3K6_HUMAN Mitogen-activated protein kinase kinase kinase 6 OS=Homo sapiens GN=MAP3K6 PE=1 SV=3 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Carbamidomethyl Cysteine | DLKPSNLLVNENCELK | | >sp|Q13164|MK07_HUMAN Mitogen-activated protein kinase 7 OS=Homo sapiens GN=MAPK7 PE=1 SV=2 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Carbamidomethyl Cysteine | DLQPVGSGAYGAVCSAVDGR | | >sp|P53778|MK12_HUMAN Mitogen-activated protein kinase 12 OS=Homo sapiens GN=MAPK12 PE=1 SV=3 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Carbamidomethyl Cysteine | ECQALEGR | | >sp|Q9Y6K9|NEMO_HUMAN NF-kappa-B essential modulator OS=Homo sapiens GN=IKBKG PE=1 SV=2 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Carbamidomethyl Cysteine | FSPEFVDFTAQCLR | | >tr|Q6FI23|Q6FI23_HUMAN MAP2K3 protein OS=Homo sapiens GN=MAP2K3 PE=2 SV=1 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Phospho (ST) | GGTVSPPPGTSR | | >sp|Q16584|M3K11_HUMAN Mitogen-activated protein kinase kinase kinase 11 OS=Homo sapiens GN=MAP3K11 PE=1 SV=1 | 11.99% | 12.55% | 13.68% | 11.44% | 12.00% | 12.13% | 10.03% | 8.73% | 12.88% | 12.32% | 12.08% | 10.02% | 11.77% | 12.45% | 12.61% | 11.66% | 9.92% | 9.04% | 12.88% | 13.21% | 13.14% | 12.18% | 10.79% | 12.85% | 13.12% | 9.55% | 7.83% | 12.11% | 13.79% | 12.52% |
Carbamidomethyl Cysteine | GLCTSPAEHQYFMTEYVATR | | >sp|Q13164|MK07_HUMAN Mitogen-activated protein kinase 7 OS=Homo sapiens GN=MAPK7 PE=1 SV=2 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Phospho (Y) | GSHQISLDNPDYQQDFFPK | | >sp|P00533|EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Carbamidomethyl Cysteine | HIDFPIPCPLR | | >sp|Q8IVH8|M4K3_HUMAN Mitogen-activated protein kinase kinase kinase kinase 3 OS=Homo sapiens GN=MAP4K3 PE=1 SV=1 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Phospho (ST) | IADPEHDHTGFLTEYVATR | | >sp|P27361|MK03_HUMAN Mitogen-activated protein kinase 3 OS=Homo sapiens GN=MAPK3 PE=1 SV=4 | 14.87% | 18.52% | 15.15% | 18.13% | 16.43% | 17.46% | 17.21% | 16.31% | 17.72% | 15.10% | 15.96% | 16.57% | 16.08% | 14.95% | 14.99% | 15.07% | 16.32% | 16.24% | 15.73% | 18.40% | 15.62% | 16.21% | 14.95% | 16.23% | 16.74% | 16.95% | 14.34% | 15.73% | 15.63% | 15.98% |
Phospho (Y) | IADPEHDHTGFLTEYVATR | | >sp|P27361|MK03_HUMAN Mitogen-activated protein kinase 3 OS=Homo sapiens GN=MAPK3 PE=1 SV=4 | 44.75% | 42.59% | 46.89% | 49.59% | 45.89% | 48.09% | 48.16% | 51.28% | 47.43% | 47.66% | 40.22% | 45.56% | 42.97% | 41.71% | 52.36% | 46.85% | 49.75% | 48.43% | 41.18% | 48.57% | 44.52% | 41.63% | 43.65% | 49.87% | 47.81% | 45.92% | 51.40% | 41.98% | 41.95% | 45.06% |
Phospho (ST) | IGEGTYGVVYK | | >sp|P06493|CDK1_HUMAN Cyclin-dependent kinase 1 OS=Homo sapiens GN=CDK1 PE=1 SV=3 | 9.08% | 8.26% | 9.44% | 8.49% | 8.35% | 8.17% | 6.81% | 7.71% | 9.59% | 8.44% | 7.99% | 8.47% | 8.24% | 7.00% | 8.98% | 9.04% | 7.03% | 7.27% | 8.64% | 8.27% | 9.44% | 9.75% | 8.31% | 8.57% | 9.12% | 7.63% | 7.18% | 8.52% | 9.09% | 8.32% |
Phospho (Y) | IGEGTYGVVYK | | >sp|P06493|CDK1_HUMAN Cyclin-dependent kinase 1 OS=Homo sapiens GN=CDK1 PE=1 SV=3 | 25.46% | 26.45% | 25.80% | 25.29% | 26.34% | 29.66% | 34.78% | 39.19% | 24.89% | 27.62% | 27.76% | 26.30% | 25.55% | 28.59% | 27.55% | 27.68% | 35.75% | 37.40% | 24.89% | 27.49% | 25.06% | 23.54% | 25.05% | 27.26% | 29.08% | 35.56% | 40.55% | 25.26% | 26.39% | 28.17% |
Phospho (ST) | IPGGNIYISPLK | | >sp|P06400|RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Phospho (ST) | ITVQASPGLDR | | >sp|Q16584|M3K11_HUMAN Mitogen-activated protein kinase kinase kinase 11 OS=Homo sapiens GN=MAP3K11 PE=1 SV=1 | 15.39% | 13.63% | 16.66% | 15.86% | 17.67% | 16.74% | 17.18% | 18.78% | 16.31% | 15.00% | 15.09% | 15.15% | 16.17% | 14.63% | 14.44% | 17.87% | 19.89% | 18.67% | 15.83% | 14.82% | 17.08% | 17.11% | 16.98% | 15.54% | 16.79% | 18.36% | 20.41% | 15.13% | 15.31% | 16.07% |
Phospho (ST) | LASPELER | | >sp|P05412|JUN_HUMAN Transcription factor AP-1 OS=Homo sapiens GN=JUN PE=1 SV=2 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Carbamidomethyl Cysteine | LCDFGVSTQLVNSIAK | | >sp|Q13163|MP2K5_HUMAN Dual specificity mitogen-activated protein kinase kinase 5 OS=Homo sapiens GN=MAP2K5 PE=1 SV=2 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Phospho (Y) | LIEDNEYTAR | | >sp|P12931|SRC_HUMAN Proto-oncogene tyrosine-protein kinase Src OS=Homo sapiens GN=SRC PE=1 SV=3 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Phospho (ST) | LNQPGTPTR | | >sp|P36507|MP2K2_HUMAN Dual specificity mitogen-activated protein kinase kinase 2 OS=Homo sapiens GN=MAP2K2 PE=1 SV=1 | 0.28% | 0.24% | 0.32% | 0.28% | 0.48% | 0.37% | 0.27% | 0.34% | 0.44% | 0.33% | 0.24% | 0.24% | 0.36% | 0.33% | 0.41% | 0.41% | 0.38% | 0.32% | 0.34% | 0.27% | 0.22% | 0.30% | 0.20% | 0.26% | 0.24% | 0.23% | 0.34% | 0.24% | 0.26% | 0.26% |
Phospho (ST) | LNTSDFQK | | >sp|Q96B36|AKTS1_HUMAN Proline-rich AKT1 substrate 1 OS=Homo sapiens GN=AKT1S1 PE=1 SV=1 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Carbamidomethyl Cysteine | LQHSPSQSYLCIPFPR | | >sp|P80192|M3K9_HUMAN Mitogen-activated protein kinase kinase kinase 9 OS=Homo sapiens GN=MAP3K9 PE=1 SV=3 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Phospho (ST) | LSASSEDISER | | >sp|Q13233|M3K1_HUMAN Mitogen-activated protein kinase kinase kinase 1 OS=Homo sapiens GN=MAP3K1 PE=1 SV=4 | 19.29% | 17.83% | 19.13% | 18.70% | 17.93% | 17.13% | 19.32% | 20.09% | 19.88% | 18.51% | 18.95% | 19.86% | 19.67% | 18.72% | 19.22% | 19.80% | 19.49% | 20.58% | 18.74% | 20.19% | 19.14% | 18.98% | 19.02% | 19.77% | 18.73% | 20.30% | 20.63% | 19.71% | 20.34% | 19.19% |
Phospho (ST) | LSASSEDISER | | >sp|Q13233|M3K1_HUMAN Mitogen-activated protein kinase kinase kinase 1 OS=Homo sapiens GN=MAP3K1 PE=1 SV=4 | 19.79% | 19.13% | 19.77% | 19.45% | 18.89% | 19.93% | 19.83% | 21.64% | 20.92% | 19.46% | 19.71% | 20.67% | 20.04% | 18.49% | 17.89% | 19.80% | 20.53% | 21.10% | 20.14% | 20.83% | 19.36% | 20.15% | 18.55% | 21.37% | 21.77% | 21.27% | 22.35% | 20.84% | 19.41% | 21.10% |
Phospho (Y) | MHLPSPTDSNFYR | | >sp|P00533|EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Carbamidomethyl Cysteine | MQSLQLDCVAVPSSR | | >sp|Q13546|RIPK1_HUMAN Receptor-interacting serine/threonine-protein kinase 1 OS=Homo sapiens GN=RIPK1 PE=1 SV=3 | 36.75% | 38.14% | 37.06% | 37.68% | 38.40% | 36.98% | 49.75% | 62.39% | 40.59% | 41.01% | 35.33% | 41.38% | 39.87% | 39.45% | 37.53% | 41.84% | 49.92% | 58.72% | 37.90% | 37.42% | 41.37% | 39.07% | 36.51% | 41.73% | 43.50% | 53.31% | 61.38% | 39.26% | 42.61% | 41.26% |
Phospho (ST) | MQSLQLDCVAVPSSR | | >sp|Q13546|RIPK1_HUMAN Receptor-interacting serine/threonine-protein kinase 1 OS=Homo sapiens GN=RIPK1 PE=1 SV=3 | 63.25% | 61.86% | 62.94% | 62.32% | 61.60% | 63.02% | 50.25% | 37.61% | 59.41% | 58.99% | 64.67% | 58.62% | 60.13% | 60.55% | 62.47% | 58.16% | 50.08% | 41.28% | 62.10% | 62.58% | 58.63% | 60.93% | 63.49% | 58.27% | 56.50% | 46.69% | 38.62% | 60.74% | 57.39% | 58.74% |
Carbamidomethyl Cysteine | MQSLQLDCVAVPSSR | | >sp|Q13546|RIPK1_HUMAN Receptor-interacting serine/threonine-protein kinase 1 OS=Homo sapiens GN=RIPK1 PE=1 SV=3 | 63.25% | 61.86% | 62.94% | 62.32% | 61.60% | 63.02% | 50.25% | 37.61% | 59.41% | 58.99% | 64.67% | 58.62% | 60.13% | 60.55% | 62.47% | 58.16% | 50.08% | 41.28% | 62.10% | 62.58% | 58.63% | 60.93% | 63.49% | 58.27% | 56.50% | 46.69% | 38.62% | 60.74% | 57.39% | 58.74% |
Phospho (ST) | MSADMSEIEAR | | >sp|O43318|M3K7_HUMAN Mitogen-activated protein kinase kinase kinase 7 OS=Homo sapiens GN=MAP3K7 PE=1 SV=1 | 14.51% | 13.70% | 13.11% | 14.06% | 15.09% | 14.28% | 10.49% | 8.81% | 14.66% | 14.60% | 13.76% | 13.95% | 15.29% | 13.71% | 14.70% | 14.01% | 11.32% | 8.96% | 13.74% | 14.48% | 13.26% | 14.39% | 13.73% | 14.70% | 13.57% | 9.94% | 9.90% | 15.21% | 14.83% | 14.55% |
Phospho (ST) | NSMTLDLNSSSK | | >sp|Q13233|M3K1_HUMAN Mitogen-activated protein kinase kinase kinase 1 OS=Homo sapiens GN=MAP3K1 PE=1 SV=4 | 14.66% | 13.61% | 14.04% | 14.19% | 15.69% | 15.86% | 20.43% | 23.76% | 14.12% | 16.13% | 12.38% | 14.87% | 14.23% | 14.55% | 14.13% | 15.81% | 21.03% | 24.32% | 15.28% | 16.12% | 15.22% | 14.88% | 15.31% | 14.68% | 15.59% | 21.09% | 25.47% | 15.86% | 14.46% | 14.17% |
Phospho (ST) | NVFEVGPGDSPTFPR | | >sp|Q16584|M3K11_HUMAN Mitogen-activated protein kinase kinase kinase 11 OS=Homo sapiens GN=MAP3K11 PE=1 SV=1 | 17.19% | 14.00% | 15.23% | 15.60% | 15.54% | 14.98% | 9.75% | 9.60% | 16.49% | 15.35% | 16.41% | 15.13% | 16.29% | 14.92% | 14.83% | 14.22% | 10.57% | 9.67% | 15.56% | 15.59% | 16.62% | 16.97% | 16.08% | 15.07% | 14.05% | 11.43% | 9.45% | 16.36% | 16.98% | 16.57% |
Carbamidomethyl Cysteine | QVGIICGQESTR | | >sp|Q15750|TAB1_HUMAN TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 OS=Homo sapiens GN=TAB1 PE=1 SV=1 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Phospho (ST) | RAPSPDGFSPYSPEETNR | | >sp|Q13233|M3K1_HUMAN Mitogen-activated protein kinase kinase kinase 1 OS=Homo sapiens GN=MAP3K1 PE=1 SV=4 | 25.64% | 26.31% | 26.37% | 26.82% | 25.44% | 27.03% | 24.07% | 21.15% | 26.63% | 28.78% | 26.89% | 28.06% | 26.53% | 28.54% | 25.39% | 26.38% | 23.16% | 21.14% | 27.61% | 27.56% | 26.89% | 27.92% | 27.85% | 28.19% | 25.42% | 24.13% | 21.02% | 25.44% | 26.32% | 28.22% |
Phospho (ST) | SIQDLTVTGTEPGQVSSR | | >sp|O43318|M3K7_HUMAN Mitogen-activated protein kinase kinase kinase 7 OS=Homo sapiens GN=MAP3K7 PE=1 SV=1 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Phospho (ST) | SSMSGLHLVK | | >sp|Q13085|ACACA_HUMAN Acetyl-CoA carboxylase 1 OS=Homo sapiens GN=ACACA PE=1 SV=2 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Phospho (Y) | TAGTSFMMTPYVVTR | | >sp|P45983|MK08_HUMAN Mitogen-activated protein kinase 8 OS=Homo sapiens GN=MAPK8 PE=1 SV=2 | 26.65% | 29.70% | 29.54% | 28.52% | 29.06% | 29.59% | 24.59% | 21.14% | 30.78% | 30.65% | 28.78% | 26.91% | 30.93% | 30.65% | 30.25% | 28.00% | 22.22% | 23.34% | 33.17% | 31.70% | 27.93% | 29.71% | 31.80% | 31.12% | 28.83% | 22.01% | 20.07% | 31.24% | 32.29% | 33.09% |
Carbamidomethyl Cysteine | TTSFAESCKPVQQPSAFGSMK | | >sp|P49841|GSK3B_HUMAN Glycogen synthase kinase-3 beta OS=Homo sapiens GN=GSK3B PE=1 SV=2 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Phospho (ST) | TTSFAESCKPVQQPSAFGSMK | | >sp|P49841|GSK3B_HUMAN Glycogen synthase kinase-3 beta OS=Homo sapiens GN=GSK3B PE=1 SV=2 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Carbamidomethyl Cysteine | VFNGCPLR | | >sp|Q12851|M4K2_HUMAN Mitogen-activated protein kinase kinase kinase kinase 2 OS=Homo sapiens GN=MAP4K2 PE=1 SV=2 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Phospho (ST) | VYTHEVVTLWYR | | >sp|P06493|CDK1_HUMAN Cyclin-dependent kinase 1 OS=Homo sapiens GN=CDK1 PE=1 SV=3 | 7.89% | 8.25% | 7.32% | 7.82% | 8.58% | 7.08% | 6.39% | 5.18% | 8.17% | 6.55% | 9.14% | 8.64% | 8.25% | 8.32% | 6.16% | 7.97% | 4.49% | 5.10% | 7.73% | 8.29% | 7.11% | 7.99% | 8.76% | 8.30% | 7.38% | 5.46% | 4.96% | 7.88% | 7.96% | 7.25% |
Phospho (Y) | VYTHEVVTLWYR | | >sp|P06493|CDK1_HUMAN Cyclin-dependent kinase 1 OS=Homo sapiens GN=CDK1 PE=1 SV=3 | 0.34% | 1.21% | 1.01% | 1.03% | 0.78% | 1.20% | 0.87% | 0.86% | 0.83% | 1.07% | 1.07% | 1.04% | 0.86% | 0.93% | 0.92% | 1.06% | 0.80% | 0.90% | 1.07% | 0.90% | 1.08% | 1.04% | 0.93% | 0.72% | 0.83% | 0.76% | 0.76% | 1.15% | 1.02% | 0.74% |